CS238601B2 - Preparation method of o-methylate hydroxyaporphines - Google Patents
Preparation method of o-methylate hydroxyaporphines Download PDFInfo
- Publication number
- CS238601B2 CS238601B2 CS788857A CS885778A CS238601B2 CS 238601 B2 CS238601 B2 CS 238601B2 CS 788857 A CS788857 A CS 788857A CS 885778 A CS885778 A CS 885778A CS 238601 B2 CS238601 B2 CS 238601B2
- Authority
- CS
- Czechoslovakia
- Prior art keywords
- carbon atoms
- substituents
- formula
- reaction
- solvent
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
- A61K31/585—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin containing lactone rings, e.g. oxandrolone, bufalin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/63—Compounds containing para-N-benzenesulfonyl-N-groups, e.g. sulfanilamide, p-nitrobenzenesulfonyl hydrazide
- A61K31/635—Compounds containing para-N-benzenesulfonyl-N-groups, e.g. sulfanilamide, p-nitrobenzenesulfonyl hydrazide having a heterocyclic ring, e.g. sulfadiazine
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Other In-Based Heterocyclic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE2757335A DE2757335C3 (de) | 1977-12-22 | 1977-12-22 | Verfahren zur O-Methylierung von Hydroxyaporphinen |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CS238601B2 true CS238601B2 (en) | 1985-12-16 |
Family
ID=6026924
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CS788857A CS238601B2 (en) | 1977-12-22 | 1978-12-22 | Preparation method of o-methylate hydroxyaporphines |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US4309542A (sv) |
| JP (1) | JPS54119474A (sv) |
| AT (1) | AT362535B (sv) |
| BE (1) | BE872843A (sv) |
| CH (1) | CH645629A5 (sv) |
| CS (1) | CS238601B2 (sv) |
| DD (1) | DD141830A5 (sv) |
| DE (1) | DE2757335C3 (sv) |
| FI (1) | FI68222C (sv) |
| FR (1) | FR2430942A1 (sv) |
| GB (1) | GB2010841B (sv) |
| HU (1) | HU177060B (sv) |
| NL (1) | NL7812394A (sv) |
| SU (1) | SU925249A3 (sv) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3118521A1 (de) * | 1981-05-09 | 1982-12-02 | Gödecke AG, 1000 Berlin | Dibenzo(de,g)chinolin-derivate, verfahren zu deren herstellung und deren verwendung bei der bekaempfung von erkaeltungskrankheiten und allergien |
| US4795759A (en) * | 1985-07-27 | 1989-01-03 | Sandoz Ltd. | Use of dibenz(CD,F)indoles |
| US6210680B1 (en) | 1999-06-11 | 2001-04-03 | Univera Pharmaceuticals, Inc. | Method for the prevention and treatment of chronic venous insufficiency |
| TWI225397B (en) * | 2000-05-04 | 2004-12-21 | Nat Science Council | Uses of thaliporphine or its derivatives in treatment of cardiac diseases and preparation of the same |
| RU2350326C2 (ru) * | 2000-08-23 | 2009-03-27 | Лотус Фармасьютикал Ко., Лтд | Применение талипорфина или его производных в лечении заболеваний сердца, а также их получение |
| AU2003242227A1 (en) * | 2003-06-19 | 2005-01-04 | Lotus Pharmaceutical Co., Ltd. | Aporphine and oxoaporphine and the medical use thereof |
| CN1884265A (zh) * | 2005-06-20 | 2006-12-27 | 美时化学制药股份有限公司 | 治疗糖尿病的阿朴芬及次阿朴芬化合物 |
| WO2007134485A1 (en) * | 2006-05-22 | 2007-11-29 | Lotus Pharmaceutical Co., Ltd. | Aporphine and oxoaporphine compounds and pharmaceutical use thereof |
| TWI531369B (zh) * | 2014-05-30 | 2016-05-01 | 資元堂生物科技股份有限公司 | 阿朴啡生物鹼衍生物用於製備促進ａｍｐｋ活性的藥物之用途 |
| CN111196801B (zh) * | 2020-01-14 | 2022-10-14 | 中国药科大学 | 阿朴菲类生物碱衍生物及其制备方法与用途 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US1100998A (en) * | 1912-05-06 | 1914-06-23 | Firm Of Mckesson & Robbins | Process of manufacuring alkyl-ethers of morphin. |
| GB1364318A (en) * | 1971-03-15 | 1974-08-21 | Bellon Labor Sa Roger | Laurotetanine derivatives |
| DE2337507A1 (de) * | 1973-07-24 | 1975-02-13 | Research Corp | Verfahren zur herstellung von aporphinen ueber neue zwischenprodukte |
| DE2625116C2 (de) * | 1976-06-04 | 1984-01-26 | Gödecke AG, 1000 Berlin | Verfahren zur Herstellung von 4-Hydroxy-aporphin-Derivaten |
-
1977
- 1977-12-22 DE DE2757335A patent/DE2757335C3/de not_active Expired
-
1978
- 1978-12-14 FR FR7835193A patent/FR2430942A1/fr active Granted
- 1978-12-18 BE BE192382A patent/BE872843A/xx not_active IP Right Cessation
- 1978-12-19 US US05/971,143 patent/US4309542A/en not_active Expired - Lifetime
- 1978-12-19 GB GB7849004A patent/GB2010841B/en not_active Expired
- 1978-12-20 DD DD78209943A patent/DD141830A5/de unknown
- 1978-12-21 AT AT913578A patent/AT362535B/de not_active IP Right Cessation
- 1978-12-21 JP JP15695578A patent/JPS54119474A/ja active Pending
- 1978-12-21 FI FI783951A patent/FI68222C/fi not_active IP Right Cessation
- 1978-12-21 SU SU782700555A patent/SU925249A3/ru active
- 1978-12-21 HU HU78WA355A patent/HU177060B/hu unknown
- 1978-12-21 CH CH1305678A patent/CH645629A5/de not_active IP Right Cessation
- 1978-12-21 NL NL7812394A patent/NL7812394A/xx not_active Application Discontinuation
- 1978-12-22 CS CS788857A patent/CS238601B2/cs unknown
Also Published As
| Publication number | Publication date |
|---|---|
| FI68222C (fi) | 1985-08-12 |
| GB2010841B (en) | 1982-08-18 |
| DE2757335B2 (de) | 1981-05-27 |
| HU177060B (hu) | 1981-06-28 |
| GB2010841A (en) | 1979-07-04 |
| FI68222B (fi) | 1985-04-30 |
| FR2430942A1 (fr) | 1980-02-08 |
| SU925249A3 (ru) | 1982-04-30 |
| FR2430942B1 (sv) | 1985-02-22 |
| DD141830A5 (de) | 1980-05-21 |
| AT362535B (de) | 1981-05-25 |
| DE2757335C3 (de) | 1982-03-25 |
| DE2757335A1 (de) | 1979-06-28 |
| US4309542A (en) | 1982-01-05 |
| BE872843A (fr) | 1979-04-17 |
| CH645629A5 (de) | 1984-10-15 |
| FI783951A (fi) | 1979-06-23 |
| JPS54119474A (en) | 1979-09-17 |
| ATA913578A (de) | 1980-10-15 |
| NL7812394A (nl) | 1979-06-26 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP0179383B1 (en) | 9-amino-1,2,3,4-tetrahydroacridin-1-ol and related compounds, a process for their preparation and their use as medicaments | |
| CS238601B2 (en) | Preparation method of o-methylate hydroxyaporphines | |
| HU185133B (en) | Process for producing 1-hydroxy-octahydro-benzo-bracket-c-bracket closed-quinolines and derivatives | |
| JPS6113472B2 (sv) | ||
| EP2170840A1 (en) | An improved process for preparing purine derivative | |
| US4013666A (en) | (8α,13Aβ)-8-CARBOCYCLIC/CARBOCYCLIC METHYL-5,8,13,13A-TETRAHYDRO-2,3,10,11-TETRAMETHOXY-6H-dibenzo[a,g]quinolizines and intermediates thereto | |
| EP0099303B1 (fr) | Nouvelles benzothiopyranopyridinones et leurs sels, leur préparation, leur application comme médicaments et les compositions les renfermant | |
| DK141629B (da) | Analogifremgangsmaade til fremstilling af 7alfasubstituerede n-(furylmethyl)-6,14-endoetheno-eller-6,14-endoethano-tetrahydronororipaviner eller syreadditionssalte deraf | |
| US4336192A (en) | 5,6-Dihydro-11-alkylene-morphanthridin-6-ones | |
| US4656179A (en) | Isoquinoline derivatives, and pharmaceutical compositions containing them | |
| FR2510575A1 (fr) | Nouveaux composes bicycliques, leur procede de preparation et composition pharmaceutique les renfermant | |
| EP0202950B1 (en) | Berban derivatives and their preparation and pharmaceutical formulation | |
| SU493965A3 (ru) | Способ получени д-2-замещенных-6-алкил8-замещенных эрголинов | |
| FI85702C (sv) | Förfarande för framställning av tert.-butyl-ergolinderivat | |
| Shutske et al. | Synthesis of Some amino‐4, 5‐dihydropyrazolo [3, 4‐a] acridines as potential cholinesterase inhibitors | |
| EP0026505A1 (en) | 7,8-Substituted-1-phenyl-2,3,4,5-tetrahydro-1-H-3-benzazepines | |
| US3983122A (en) | Process for the preparation of quinolizinone derivatives | |
| EP0015786B1 (fr) | Imidazo et pyrimido-pyrido-indoles, leur préparation et médicaments les contenant | |
| US3635962A (en) | 4 - bis-morpholino- and 2 | |
| CS196323B2 (en) | Method of producing novel derivatives of isoindoline | |
| US4013644A (en) | [8 α(E), 13aβ]-5,8,13,13a-tetrahydro-2,3,10,11-tetramethoxy-8-(2-phenylethenyl)-6H-dibenzo[a,g]quinolizines and intermediates thereto | |
| Kotick et al. | 8β‐Substituted dihydrocodeinones having heteroatoms in the side chain | |
| KR800001551B1 (ko) | 환상 화합물의 제조방법 | |
| US4713386A (en) | Tetrahydroazeto [2,1-a]isoquinolines and methods for treating depression | |
| US4202821A (en) | N-(N'-Methylenepyrrolidonyl)-2-substituted anilines |